Related Experiment Video
Updated: Apr 6, 2026

07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
12.5K
CONGENITAL HEART MALFORMATIONS IN NEWBORN BABIES WITH LOW BIRTH WEIGHT
Summary
Congenital heart malformations are a significant public health issue, particularly in low birth weight newborns. Early detection and interdisciplinary collaboration are crucial for managing these complex cardiovascular diseases.
Area of Science:
- Cardiology
- Pediatrics
- Public Health
Background:
- Congenital heart malformations (CHMs) are a major public health concern.
- CHMs occur frequently in low birth weight newborns, increasing complication risks.
- Understanding CHM epidemiology in this population is vital for timely therapeutic approaches.
Purpose of the Study:
- To investigate the epidemiology of cardiovascular malformations in low birth weight newborns.
- To explore correlations between CHMs and genetic/environmental factors.
- To assess complications and guide therapeutic management.
Main Methods:
- Retrospective study of 271 pediatric cardiology patients (Jan 2011-Dec 2013).
- Data collected via anamnesis, clinical, biological, and imagistic examinations.
- Patients analyzed based on malformation type, origin, and birth weight status.
Main Results:
- CHMs accounted for 44.13% of pediatric cardiovascular hospitalizations.
- Non-cyanogenic CHMs (95%) were more prevalent than cyanogenic (5%).
- High incidence in premature low birth weight (48%) and very low birth weight (22%) infants; 71% from rural areas. Common complications include heart failure, hypertension, and respiratory infections. Mortality peaked in the first year, with one-third linked to chromosomal abnormalities.
Conclusions:
- CHMs in low birth weight newborns represent a substantial portion of pediatric cardiovascular cases.
- Association with other congenital anomalies and complications necessitates interdisciplinary care.
- Close monitoring of anatomical and functional parameters is essential for optimal development.
Related Concept Videos
Teratogenicity
4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Neurulation
47.4K
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.4K
Fetal Circulation
4.7K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.7K
Mitral Stenosis I: Introduction
1.4K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
741
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
741

